1256: Lower Tumor Expression Levels of the Transforming Growth Factor Beta Receptor Type II Protein are Associated with a Less Aggressive Tumor Phenotype and Improved Survival Among Patients with Clear Cell Renal Cell Carcinoma

You have accessJournal of UrologyModerated Poster 37, Tuesday, May 22, 2007, 8:00 - 10:00 am1 Apr 20071256: Lower Tumor Expression Levels of the Transforming Growth Factor Beta Receptor Type II Protein are Associated with a Less Aggressive Tumor Phenotype and Improved Survival Among Patients with Clear Cell Renal Cell Carcinoma Alexander S. Parker, Christine M. Lohse, Kevin Wu, John Copland, Michael Wehle, and John C. Cheville Alexander S. ParkerAlexander S. Parker More articles by this author , Christine M. LohseChristine M. Lohse More articles by this author , Kevin WuKevin Wu More articles by this author , John CoplandJohn Copland More articles by this author , Michael WehleMichael Wehle More articles by this author , and John C. ChevilleJohn C. Cheville More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)31470-8AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "1256: Lower Tumor Expression Levels of the Transforming Growth Factor Beta Receptor Type II Protein are Associated with a Less Aggressive Tumor Phenotype and Improved Survival Among Patients with Clear Cell Renal Cell Carcinoma." The Journal of Urology, 177(4S), p. 414 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 177Issue 4SApril 2007Page: 414 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Alexander S. Parker More articles by this author Christine M. Lohse More articles by this author Kevin Wu More articles by this author John Copland More articles by this author Michael Wehle More articles by this author John C. Cheville More articles by this author Expand All Advertisement Loading ...